Please check your internet connection and try again.
### Sompraz
**Overview**
Sompraz (pantoprazole) is a proton pump inhibitor (PPI) that reduces gastric acid production.
**Primary Indications**
* Healing of erosive esophagitis associated with GERD
* Maintenance of healing of erosive esophagitis
* Treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome
**Adult Dosing**
* **Healing of Erosive Esophagitis:** 40 mg orally once daily for up to 8 weeks.
* **Maintenance of Healing of Erosive Esophagitis:** 40 mg orally once daily.
* **Pathological Hypersecretory Conditions:** Starting dose of 40 mg orally twice daily. Doses can be increased as needed. Typical doses range from 40 mg to 240 mg per day. Maximum recommended daily dose is 240 mg.
**Pediatric Dosing**
* **Healing of Erosive Esophagitis (ages 5 to 16 years):** 20 mg to 40 mg orally once daily for up to 8 weeks.
* **Gastroesophageal Reflux Disease (GERD) symptoms (ages 5 to 16 years):** 20 mg to 40 mg orally once daily.
**Dose Adjustments**
* **Hepatic Impairment:** Maximum daily dose of 20 mg orally once daily.
* **Renal Impairment:** No dose adjustment needed.
**Contraindications**
* Known hypersensitivity to pantoprazole or any component of the formulation.
**Adverse Effects**
Common: Headache, diarrhea, nausea, abdominal pain, vomiting, dizziness, fatigue.
Less Common: Rash, itching, joint pain, elevated liver enzymes.
Long-term use of PPIs, including pantoprazole, may be associated with an increased risk of bone fractures, *Clostridium difficile*-associated diarrhea, vitamin B12 deficiency, and hypomagnesemia.
**Key Drug Interactions**
* **Drugs requiring gastric acid for absorption:** Pantoprazole can decrease gastric acidity, potentially reducing the absorption of drugs like ketoconazole, itraconazole, and certain HIV protease inhibitors.
* **Warfarin:** May increase INR and prothrombin time. Monitor INR closely.
* **Methotrexate:** PPIs may increase methotrexate levels; consider temporary discontinuation of pantoprazole.
**Monitoring**
* Monitor for signs and symptoms of *Clostridium difficile*-associated diarrhea.
* Monitor magnesium levels, especially in patients on long-term therapy or those taking diuretics concurrently.
* Monitor for bone fracture risk in patients with risk factors for osteoporosis.
* For patients on warfarin, monitor INR.
**Clinical Pearls**
* Administer pantoprazole at least 30 minutes before a meal.
* Pantoprazole delayed-release tablets should be swallowed whole and not chewed, cut, or crushed.
* Long-term PPI use should be reserved for patients with a clear indication.
**Disclaimer:** This information is intended for clinical decision support and does not replace the need to consult the current official prescribing information and relevant literature before making any therapeutic decisions. Dosing and indications may vary based on local protocols and individual patient factors.
